Conference item : Abstract
Safety and Clinical Activity of Mutant IDH1 Inhibitor IVOSIDENIB (IVO; AG-120) In Combination with AZACITIDINE (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML)
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
- Publisher:
- Springer
- Host title:
- Annals of Hematology
- Journal:
- Annals of Hematology More from this journal
- Volume:
- 98
- Issue:
- S1
- Pages:
- S40-S41
- Publication date:
- 2019-02-12
- DOI:
- EISSN:
-
1432-0584
- ISSN:
-
0939-5555
- Keywords:
- Subtype:
-
Abstract
- Pubs id:
-
pubs:981072
- UUID:
-
uuid:68b7d4ad-7c97-4ca3-a933-7b70cfd37241
- Local pid:
-
pubs:981072
- Source identifiers:
-
981072
- Deposit date:
-
2019-04-04
Terms of use
- Copyright date:
- 2019
If you are the owner of this record, you can report an update to it here: Report update to this record